目前我国脑卒中的发病率居于所有疾病之首,致死率及致残率极高,其中大面积脑梗塞由于其并发症及合并症多且重,故其临床预后更差。目前对大面积脑梗塞的治疗主要是临床常规药物治疗,虽有一定疗效,但治疗时间长、机体恢复慢,且近年来的动静脉溶栓疗法因有严格的禁忌证而受到限制 At present, the incidence of stroke in our country living in the first of all diseases, mortality and disability rate is extremely high, of which large area due to complications of cerebral infarction and complications and more, so its clinical prognosis worse. The current treatment of large areas of cerebral infarction is mainly clinical conventional drug treatment, although a certain effect, but the treatment of a long time, the body recovered slowly, and in recent years, arteriovenous thrombolytic therapy due to strict contraindications and restrictions